CASE DISCUSSION
Pulmonary Hypertension: A Case-Based Approach
Presented India by Dr. M. V. RamachandraViews
18,050
Credit Points
Learning Hours
CPD Points
CME Points
Courses Completed
Case Description
Pulmonary hypertension is a progressive and debilitating condition characterized by elevated blood pressure in the pulmonary arteries, leading to impaired functioning of the heart and lungs. This case-based approach focuses on individual patient scenarios to understand the diverse causes, clinical...
Case Summary
- The mean pulmonary artery pressure is normally 14 plus or minus 3, and pulmonary hypertension is defined as a mean pulmonary artery pressure greater than 20, according to current European Respiratory Society guidelines. This measurement is ideally obtained via right heart catheterization, considered the gold standard, though it's not routinely performed on all patients. Pulmonary hypertension is classified into five groups, with Group 1 specifically termed "pulmonary arterial hypertension" and including idiopathic, heritable, drug/toxin-induced, and associated conditions like connective tissue disorders, HIV, portal hypertension, congenital heart disease (specifically shunting types), pulmonary veno-occlusive disease, and persistent pulmonary hypertension of the newborn.
Speaker Profile
Dr. M. V. Ramachandra
Consultant Pulmonologist, Kauvery HospitalsDr. M. V. Ramachandra is a Respiratory Medicine specialist and Consultant Pulmonologist at Kauvery Hospitals.
He has expertise in the diagnosis and management of respiratory disorders including asthma, COPD, lung infections, and sleep-related breathing disorders.
His clinical interests include interventional pulmonology, critical respiratory care, and preventive lung health.
He is committed to delivering evidence-based and patient-centered pulmonary care using advanced diagnostic and treatment approaches.
Through his clinical practice, he contributes to improving respiratory health outcomes and awareness in the community.
Disclosures
Assimilate requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships for anyone with the ability to control the content of this educational activity have been reviewed and mitigated. Others involved in the planning of this activity have no relevant financial relationships.